Healthwell Foundation is located in Germantown, MD. The organization was established in 2005. According to its NTEE Classification (E99) the organization is classified as: Health Care N.E.C., under the broad grouping of Health Care and related organizations. As of 12/2023, Healthwell Foundation employed 234 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Healthwell Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Healthwell Foundation generated $742.4m in total revenue. This organization has experienced exceptional growth, as over the past 9 years, it has increased revenue by an average of 30.4% each year . All expenses for the organization totaled $721.5m during the year ending 12/2023. While expenses have increased by 30.1% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
IMPROVING ACCESS TO HEALTH CARE FOR AMERICA'S UNDERINSURED.
Describe the Organization's Program Activity:
Part 3 - Line 4a
MULTIPLE MYELOMA - MEDICARE ACCESS - PROVIDED DEDUCTIBLE, COINSURANCE, COPAYMENT AND PREMIUM ASSISTANCE TO 29,383 ELIGIBLE MEDICARE PATIENTS RECEIVING TREATMENT FOR MULTIPLE MYELOMA.
THE HEALTHWELL FOUNDATION PROVIDED DEDUCTIBLE, COINSURANCE, COPAYMENT, AND PREMIUM ASSISTANCE TO 125,790 ELIGIBLE PATIENTS TREATED FOR HEPATITIS C, TARDIVE DYSKINESIA, PROSTATE CANCER, PULMONARY HYPERTENSION, CARDIOMYOPATHY, CHRONIC LYMPHOCYTIC LEUKEMIA, ACUTE MYELOID LEUKEMIA, CYSTIC FIBROSIS, PULMONARY FIBROSIS, MYELODYSPLASTIC SYNDROMES, NEUROCOGNITIVE DISEASE WITH PSYCHOSIS, AMYOTROPHIC LATERAL SCLEROSIS, BREAST CANCER, MULTIPLE SCLEROSIS, PEYRONIE'S DISEASE, CYSTIC FIBROSIS VITAMINS AND SUPPLEMENTS, MANTLE CELL LYMPHOMA, CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY, PEDIATRIC ASSISTANCE, DUPUYTREN'S DISEASE, AMYLOIDOSIS, GOUT, NON-SMALL CELL LUNG CANCER, NON-HODGKIN'S LYMPHOMA, SMALL CELL LUNG CANCER, SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE, WALDENSTROM MACROGLOBULINEMIA, URTICARIA, SICKLE CELL DISEASE, TYPE 2 DIABETES, MELANOMA, COLORECTAL CARCINOMA, CUSHING'S DISEASE, PANCREATIC CANCER, POST MENOPAUSAL OSTEOPOROSIS, IGA NEPHROPATHY, BLEPHARITIS, LAMBERT-EATON MYASTHENIC SYNDROME, GIANT CELL ARTERITIS OR TEMPORAL ARTERITIS, CHRONIC MYELOID LEUKEMIA, BLADDER AND UROTHELIAL CANCER, AAV & GPA, HEALTH ACCESS, BONE METASTASES, B-CELL LYMPHOMA, ANCA-ASSOC VASCULITIS, AND GRANULOMATOSIS WITH POLYANGIITIS (FORMERLY WEGENERS), NONTUBERCULOUS MYCOBACTERIUM, CANCER-RELATED BEHAVIORAL HEALTH, CHEMOTHERAPY INDUCED NEUTROPENIA, OVARIAN CANCER, PORPHYRIAS, HEAD AND NECK CANCER, COVID-19 FRONTLINE HEALTH CARE WORKERS BEHAVIORAL HEALTH, GASTRIC CANCER, HYPEROXALURIA, HOMOCYSTINURIA, GOUT TRAVEL FUND, UREA CYCLE DISORDERS, ACROMEGALY, WILMS' TUMOR, AND ALAGILLE SYNDROME VITAMINS AND SUPPLEMENTS.
RENAL CELL CARCINOMA - MEDICARE ACCESS - PROVIDED DEDUCTIBLE, COINSURANCE, COPAYMENT AND PREMIUM ASSISTANCE TO 9,547 ELIGIBLE MEDICARE PATIENTS RECEIVING TREATMENT FOR RENAL CELL CARCINOMA.
HYPERCHOLESTEROLEMIA - MEDICARE ACCESS - PROVIDED DEDUCTIBLE, COINSURANCE, COPAYMENT AND PREMIUM ASSISTANCE TO 52,454 ELIGIBLE MEDICARE PATIENTS BEING TREATED FOR HYPERCHOLESTEROLEMIA.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Stephen M Weiner Board Member & Chief Compl. Officer | OfficerTrustee | 1 | $32,388 |
David L Knowlton Board Chair | OfficerTrustee | 2 | $48,276 |
Nancy Carteron MD Facr Board Member | Trustee | 1 | $17,816 |
Suzanne M Miller PHD Vice Chair & Secretary | OfficerTrustee | 1 | $12,000 |
Jerri Scarzella Bsn Vice Chair & Treasurer | OfficerTrustee | 1 | $12,000 |
David F Ertel Board Member Thru 8/23 | Trustee | 1 | $4,500 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Vonage Business Inc Telecom Services | 12/30/23 | $437,906 |
Pharmacy Data Management Inc Pharmacy Claims Processing | 12/30/23 | $992,557 |
Salesforceorg Grants Management System | 12/30/23 | $273,885 |
Ab Data Direct Mail | 12/30/23 | $204,334 |
Experian Health Verification Services For Applicants | 12/30/23 | $188,642 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $730,901,028 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $730,901,028 |
Total Program Service Revenue | $32,198 |
Investment income | $16,272,559 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$4,841,567 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $742,364,218 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $695,015,656 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $1,553,057 |
Compensation of current officers, directors, key employees. | $967,615 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $13,630,856 |
Pension plan accruals and contributions | $430,423 |
Other employee benefits | $3,126,405 |
Payroll taxes | $867,839 |
Fees for services: Management | $0 |
Fees for services: Legal | $212,084 |
Fees for services: Accounting | $198,553 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $423,341 |
Fees for services: Investment Management | $266,048 |
Fees for services: Other | $1,974,550 |
Advertising and promotion | $92,967 |
Office expenses | $646,192 |
Information technology | $558,233 |
Royalties | $0 |
Occupancy | $966,190 |
Travel | $225,385 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $267,694 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $177,244 |
Insurance | $101,394 |
All other expenses | $0 |
Total functional expenses | $721,499,830 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $67,443,198 |
Savings and temporary cash investments | $126,704,265 |
Pledges and grants receivable | $54,753,671 |
Accounts receivable, net | $28,522 |
Loans from Officers, Directors, or Controlling Persons | $3,220 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $55,919 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $807,955 |
Net Land, buildings, and equipment | $517,904 |
Investments—publicly traded securities | $381,722,305 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $1,300 |
Other assets | $5,794,512 |
Total assets | $637,832,771 |
Accounts payable and accrued expenses | $68,481,966 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $13,074,105 |
Total liabilities | $81,556,071 |
Net assets without donor restrictions | $37,685,821 |
Net assets with donor restrictions | $518,590,879 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $637,832,771 |